0001209191-14-060584.txt : 20141001
0001209191-14-060584.hdr.sgml : 20141001
20141001171148
ACCESSION NUMBER: 0001209191-14-060584
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140930
FILED AS OF DATE: 20141001
DATE AS OF CHANGE: 20141001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 141133858
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-09-30
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197032
SMITH IAN F
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP & CFO
Common Stock
2014-09-30
4
M
0
2267
33.28
A
47537
D
Common Stock
2014-09-30
4
M
0
13594
39.05
A
61131
D
Common Stock
2014-09-30
4
M
0
11329
33.82
A
72460
D
Common Stock
2014-09-30
4
M
0
16993
38.80
A
89453
D
Common Stock
2014-09-30
4
M
0
11330
51.75
A
100783
D
Common Stock
2014-09-30
4
M
0
16993
37.86
A
117776
D
Common Stock
2014-09-30
4
M
0
18126
48.74
A
135902
D
Common Stock
2014-09-30
4
M
0
16992
45.11
A
152894
D
Common Stock
2014-09-30
4
S
0
14007
111.31
D
138887
D
Common Stock
2014-09-30
4
S
0
43112
112.21
D
95775
D
Common Stock
2014-09-30
4
S
0
28751
113.10
D
67024
D
Common Stock
2014-09-30
4
S
0
22156
113.90
D
44868
D
Common Stock
5306
I
401(k)
Stock Option (right to buy)
33.28
2014-09-30
4
M
0
2267
0.00
D
2019-07-15
Common Stock
2267
0
D
Stock Option (right to buy)
39.05
2014-09-30
4
M
0
13594
0.00
D
2020-02-03
Common Stock
13594
0
D
Stock Option (right to buy)
33.82
2014-09-30
4
M
0
11329
0.00
D
2020-07-13
Common Stock
11329
0
D
Stock Option (right to buy)
38.80
2014-09-30
4
M
0
16993
0.00
D
2021-02-02
Common Stock
16993
10195
D
Stock Option (right to buy)
51.75
2014-09-30
4
M
0
11330
0.00
D
2021-07-12
Common Stock
11330
9062
D
Stock Option (right to buy)
37.86
2014-09-30
4
M
0
16993
0.00
D
2022-02-01
Common Stock
16993
23789
D
Stock Option (right to buy)
48.74
2014-09-30
4
M
0
18126
0.00
D
2022-07-24
Common Stock
18126
18124
D
Stock Option (right to buy)
45.11
2014-09-30
4
M
0
16992
0.00
D
2023-02-04
Common Stock
16992
37383
D
Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $111.31 (range $110.61 to $111.60).
Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $112.21 (range $111.61 to $112.60).
Open market sales reported on this line occurred at a weighted average price of $113.10 (range $112.61 to $113.59).
Open market sales reported on this line occurred at a weighted average price of $113.90 (range $113.61 to $114.34).
The option vests in 16 quarterly installments from 07/16/2009.
The option vests in 16 quarterly installments from 02/04/2010.
The option vests in 16 quarterly installments from 07/14/2010.
The option vests in 16 quarterly installments from 02/03/2011.
The option vests in 16 quarterly installments from 07/13/2011.
The option vests in 16 quarterly installments from 02/02/2012.
The option vests in 16 quarterly installments from 07/25/2012.
The option vests in 16 quarterly installments from 02/05/2013.
Kenneth L. Horton, Attorney-In-Fact
2014-10-01